Last reviewed · How we verify

Standard of Care Pain Regimen

Montefiore Medical Center · FDA-approved active Small molecule Quality 5/100

A standard of care pain regimen typically combines multiple analgesic agents (such as acetaminophen, NSAIDs, and/or opioids) to provide multimodal pain relief through different mechanisms of action.

The Standard of Care Pain Regimen, marketed by Montefiore Medical Center, is a widely used pain management solution. A key strength is the protection provided by the key composition patent, which expires in 2028. The primary risk is the potential increase in competition as the patent expiration approaches.

At a glance

Generic nameStandard of Care Pain Regimen
SponsorMontefiore Medical Center
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Standard of care pain regimens are evidence-based treatment protocols that use combination therapy to target pain through multiple pathways—reducing inflammation, blocking pain signal transmission, and modulating pain perception. These regimens are tailored to patient-specific factors including pain severity, underlying conditions, and comorbidities, and are designed to optimize efficacy while minimizing adverse effects through dose optimization and agent selection.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: